August 27, 2020 - Events & training
New webinar series addresses key topics in medical oncology
BD oncology webinar series Oncology experts and clinicians will be sharing their experience and expertise on the impact of medical…
July 27, 2020 - News & Innovation
Preparing for COVID-19 vaccinations in Europe
The COVID-19 crisis has touched all of mankind The COVID-19 crisis has touched all of mankind, with no country immune...
July 27, 2020 - Events & training
PICC or port, which device for patients with cancer?
The choice of vascular access device (VAD) is critical in oncology. Oncology professionals must consider multiple factors. Different options involve...
Save one life and you’re a hero, save a hundred, and you’re a nurse— Anonymous Nurses have a critical role...
July 27, 2020 - Scientific Publications
Case report analysis from a prospective, multisite study of oncology nurses’ exposure in ambulatory settings1 Nurses, clinicians and other healthcare...
July 27, 2020 - Events & training
BD supports WoCoVa live! on vascular access and COVID-19
Coronavirus disease 2019 (COVID-19) has had a significant impact on vascular access (VA) Coronavirus disease 2019 (COVID-19) has had a...
A 2-fold increased risk
Exposure to antineoplastic drugs is associated with a 2-fold increased risk of spontaneous abortion, particularly with early spontaneous abortion before...
Contact us
Fast fact
213 drugs have been listed 213* Drugs have been listed in the US National Institute of Occupational Health and Safety (NIOSH) List of Hazardous Drugs in Healthcare Settings, 2016. 1 Healthcare workers can be protected from the effects of hazardous drug exposure through engineering and administrative controls, and proper protective equipment.2